Clinical Research Directory
Browse clinical research sites, groups, and studies.
China Diabetes Type 1 Study (CD1S) by China Alliance for Type 1 Diabetes
Sponsor: Second Xiangya Hospital of Central South University
Summary
The aim of the China Diabetes Type 1 Study (CD1S) is to conduct a nationwide type 1 diabetes (T1D) registry study in patients with T1D and in pediatric adolescent patients with diabetes who had an age of onset \<= 20 years. CD1S compromises a retrospective study enrolling inpatients hospitalized from Jan 1st, 2016 to Dec 31, 2021, and a prospective study beginning from the year 2022.
Key Details
Gender
All
Age Range
Any - Any
Study Type
OBSERVATIONAL
Enrollment
20000
Start Date
2022-01-01
Completion Date
2035-12-31
Last Updated
2022-08-12
Healthy Volunteers
No
Conditions
Interventions
Standard type 1 diabetes management model constructed by China Alliance for Type 1 Diabetes in each center
Standard type 1 diabetes management model constructed by China Alliance for Type 1 Diabetes in each center
Locations (11)
Gansu Provincial People's Hospital
Lanzhou, Gansu, China
Shenzhen Second People's Hospital
Shenzhen, Guangdong, China
Hainan General Hospital
Haikou, Hainan, China
the First Affiliated Hospital of Harbin Medical University
Harbin, Heilongjiang, China
The First Affiliated Hospital of Henan University of Science and Technology
Luoyang, Henan, China
The Second Xiangya Hospital, Central South University
Changsha, Hunan, China
The First Affiliated Hospital of Nanjing Medical University
Nanjing, Jiangsu, China
Heji Hospital Affiliated to Changzhi Medical College
Changzhi, Shanxi, China
The First Affiliated Hospital of Xinjiang Medical University
Ürümqi, Xinjiang, China
The First People's Hospital of Yunnan
Kunming, Yunnan, China
Zhejiang Provincial People's Hospital
Hangzhou, Zhejiang, China